Products

Clonemysaas

clone proven profitable ai photo businesses ($3.4m+ arr). get complete codebase with flux ai model, stripe payments, and auth. launch your own ai startup in 2 weeks like cvphoto.app ($2k mrr).

clonemysaas.com Finance / Invoicing & Payments

AI Benchmark
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Johnny Tran
No social account linked
Launched
18mo ago
2025-05-16 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions

  • Launched on IndiePageLaunch

    Clonemysaas — Codebase of profitable SaaS

    May 16, 2025 · 18mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2024-09-02

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-09-15

Key pages

Weekly snapshots

No page snapshots yet. Once followed, home and pricing pages are captured weekly.

    Changes

    No pricing, plan, or positioning changes detected since tracking started.

    Questions & evidence

    How much website traffic does Clonemysaas get?
    Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
    What is Clonemysaas and what platforms does it support?
    Clonemysaas is catalogued under Invoicing & Payments: clone proven profitable ai photo businesses ($3.4m+ arr). get complete codebase with flux ai model, stripe payments, and auth. launch your own ai startup in 2 weeks like cvphoto.app ($2k mrr).. Supported platforms: Web.

    Related products in this category

    Finance / Invoicing & Payments

    These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.